IRS Issues Final Rule Implementing Medical Device Excise Tax
The Internal Revenue Service released a
implementing a Patient Protection and Affordable Care Act provision that imposes on certain medical devices made after 2012 an excise tax equal to 2.3% of their sales price. In submitted on the proposed rule AHRMM, the American Hospital Association and others urged the IRS to explicitly prohibit device companies from passing the tax on to customers, and to clarify that hospitals and other healthcare providers who package and sterilize devices for use in surgery kits should not be treated as device manufacturers or importers under the rule. The final rule does not address AHRMM’s recommendation that manufacturers certify that the tax has not been passed on to customers, but provides that current rules apply in determining the sales price of items. Also, of importance, the final rule states that a kit produced by a hospital or medical institution for its own use would not be a taxable medical device.Related Resources
On-Demand Educational Webinars
Developing a clinically integrated supply chain can lead to organizational savings, a decrease in ordering of supplies outside of the supply chain,…
On-Demand Educational Webinars
The supply chain ecosystem has contributed to the 25% waste in the health care system. We can accept that reality while at the same time learning to…
e-Learning
Earn the Essentials of Inventory Control Certificate, this inventory management certification is a core health care supply chain discipline.
Podcasts
A short introduction to the CMS Meaningful Use 3 Rule and how implementing UDI within the healthcare setting and moving toward the full GS1 will re